NIH Researcher Examines Sepsis and Acute Kidney Injury in Schrier Lectureship

Robert A. Star


The complex relationship between sepsis and acute kidney injury will be examined in the Robert W. Schrier Endowed Lectureship, titled, “Sepsis AKI: Kidney as Amplifier and Target,” on Thursday, Nov. 1, at 2 p.m.

The speaker will be Robert A. Star, MD, director of the Division of Kidney, Urologic, and Hematologic Diseases at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). He is also a senior investigator and chief of the renal diagnostics and therapeutics unit at the NIDDK.

Dr. Star has a particular interest in translational research. His laboratory focuses on the early identification, prevention, and preemption of sepsis and acute kidney injury. His research has produced more than 120 published manuscripts. He has written eight textbook chapters and holds several patents.

Dr. Star was a postdoctoral fellow at the National Institutes of Health (NIH) in the mid-1980s before joining the faculty of the University of Texas Southwestern Medical Center in Dallas. In 1999, he returned to NIH as a senior scientific advisor for kidney disease and to run a lab studying acute kidney injury. In 2002, he became senior advisor for clinical research in the NIH Office of Science Policy and Planning, where he worked on the NIH roadmap for medical research initiatives to re-engineer the clinical research enterprise. The roadmap aims to stimulate research and develop resources for cross-cutting, large, and complex projects with profound potential impact. He also led training and career programs for clinical researchers and helped develop the clinical and translational science awards.

Dr. Star graduated summa cum laude in applied mathematics from Harvard College and cum laude from the Harvard Medical School–Massachusetts Institute of Technology Joint Program in Health Sciences and Technology. His internship and residency in internal medicine were performed at Michael Reese Hospital in Chicago.

Dr. Star has received honorary awards and research support from NIH and the U.S. Food and Drug Administration. He received the Young Investigator Award recognizing excellence in nephrology research, jointly awarded by the American Society of Nephrology and the American Heart Association.


[1] ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier Endowed Lectureship.

October-November 2012 (Volume 4, Number 10 & 11)